Kerri Nottage, MD

Kerri Nottage, MD, MPH

Assistant Member, St. Jude Faculty

Departments

Hematology

Contact Information

Kerri Nottage, MD, MPH
Hematology
MS 800, Room R5013
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105-3678
Email: kerri.nottage@stjude.org
Phone: (901) 595-6216
FAX: (901) 595-2952

Education

BS – University of Rhode Island, Kingston, Rhode Island
MPH (Epidemiology Concentration) - University of Memphis, Memphis, TN
MD – Brown University Medical School, Providence, Rhode Island
Internship/Residency (Internal Medicine and Pediatrics) – Rhode Island Hospital/Hasbro Children’s Hospital
Fellowship (Pediatric Hematology/Oncology) - St. Jude Children’s Research Hospital


Research Interests


Selected Publications

Nottage KA, Hankins JS, Smeltzer M, Mzayek F, Wang WC, Aygun B, Gurney JG. Hydroxyurea use and hospitalization trends in a comprehensive pediatric sickle cell program. PLoS One 8(8):e72077, 2013.

Nottage K, Gurney JG, Smeltzer M, Castellanos M, Hudson MM, Hankins JS. Trends in transfusion burden among long-term survivors of childhood hematological malignancies. Leuk Lymphoma 54(8):1719-23, 2013. PMID: 23163568

Hudson MM, Ness KK, Gurney JG, Mulrooney DA, Chemaitilly W, Krull KR, Green DM, Armstrong GT, Nottage KA, Jones KE, Sklar CA, Srivastava DK, Robison LL. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 309(22):2371-81, 2013.

Gawade PL, Ness KK, Sharma S, Li Z, Srivastava DK, Spunt SL, Nottage K, Krasin MJ, Hudson MM, Kaste SC. Association of bone mineral density with incidental renal stone in long-term survivors of childhood acute lymphoblastic leukemia. J Cancer Surviv Dec;6(4):388-97, 2012. PMID: 22956305

Nottage K, McFarlane J, Krasin MJ, Li C, Srivastava D, Robison LL, Hudson MM. Secondary colorectal carcinoma after childhood cancer. J Clin Oncol 30(20):2552-8, 2012. PMID: 22665546

Nottage K, Lanctot J, Li Z, Neglia JP, Bhatia S, Hammond S, Leisenring W, Meadows AT, Srivastava DK, Robison LL, Armstrong GT. Long-Term Risk for Secondary Leukemia after Treatment for Childhood Cancer: A Report from the Childhood Cancer Survivor Study. Blood 117(23):6315-8, 2011. PMID: 21498675

Jeng MR, Naidu PE, Rieman MD, Rodriguez-Galindo C, Nottage KA, Thornton DT, Li CS, Wang WC. Granulocyte-macrophage colony stimulating factor and immunosuppression in the treatment of pediatric acquired severe aplastic anemia. Pediatr Blood Cancer 45(2):170-5, 2005. PMID: 15593082

Last update: September 2013